Identification | Back Directory | [Name]
ACETYLSALICYLSALICYLIC ACID | [CAS]
530-75-6 | [Synonyms]
2-(Ace Acesalum Diplosalacetat DIPLOSALSALATE Diplosal Acetate Aspirin IMpurity D Aspirin Impurity 4 Aspirin EP IMpurity D ACETYLSALISYLIC ACID IMP D Acetylsalicylsalicyic acid SALICYLACETYLSALICYLIC ACID ACETYLSALICYLSALICYLIC ACID (Acetysalicylsalicyclic acid) Acetylsalicylsalicylic acid,97% 2-carboxyphenyl o-acetylsalicylate 2-(2-Acetoxybenzoyloxy)benzoic acid o-(o-Acetoxybenzoyloxy)benzoic acid 2-[[2-(Acetyloxy)benzoyl]oxy]benzoic acid 2-((2-Acetoxybenzoyl)oxy)benzoic acid,95+% 2-(Acetyloxy)benzoic Acid 2-Carboxyphenyl Ester 2-[[(2-Acetyloxyphenyl)carbonyl]oxy]benzoic acid Benzoic acid, 2-(acetyloxy)-, 2-carboxyphenyl ester 2-HYDROXYBENZOIC ACID ACETATE 2-CARBOXYPHENYL ESTER Acetylsalicylic Acid IMpurity D (Aspirin IMpurity D) | [EINECS(EC#)]
208-493-6 | [Molecular Formula]
C16H12O6 | [MDL Number]
MFCD00143537 | [MOL File]
530-75-6.mol | [Molecular Weight]
300.26 |
Chemical Properties | Back Directory | [Appearance]
white to almost white fine crystalline powder | [Melting point ]
153-160 °C
| [Boiling point ]
361.5°C (rough estimate) | [density ]
1.346 | [refractive index ]
1.4600 (estimate) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Chloroform (Sparingly), DMSO (Sparingly), Methanol (Slightly) | [form ]
neat | [pka]
2.94±0.36(Predicted) | [color ]
White to Off-White | [Water Solubility ]
20mg/L(21 ºC) | [EPA Substance Registry System]
2-Carboxyphenyl 2-(acetyloxy)benzoate (530-75-6) |
Hazard Information | Back Directory | [Chemical Properties]
white to almost white fine crystalline powder | [Uses]
Acetylsalicylic Acid Impurity C | [Uses]
analgesic, antipyretic | [Uses]
Antiinflammatory;Cyclooxygenase inhibitor | [Definition]
ChEBI: 2-[(2-acetyloxyphenyl)-oxomethoxy]benzoic acid is a carbonyl compound. | [Purification Methods]
Crystallise the analgesic from dilute AcOH or EtOH (m 161-162o), MeOH (m 165-168o), and *C6H6/EtOH (m 163-165o). Its solubilities in boiling Et2O, *C6H6 and EtOH are 1.4%, 2.2% and 33%, respectively. [Baker et al. J Chem Soc 201 1951, Garrett et al. J Am Pharm Soc 48 684 1959, Beilstein 10 I 41, 10 II 54, 10 IV 165.] |
|
|